A motorists gets tested inside his Porsche sports car at Good Life Medical Services COVID-19 drive thru site in Los Angeles in January.

A motorists gets tested inside his Porsche sports car at Good Life Medical Services COVID-19 drive thru site in Los Angeles in January. Damian Dovarganes/AP

Biden Kept His Promise to Increase COVID-Testing Capacity, Even as Demand for Testing Drops

Experts said that the system’s capacity has improved and people now have access to different testing options.

Promise: “Double the number of drive-through testing sites, invest in next-generation testing, including at home tests and instant tests, so we can scale up our testing capacity by orders of magnitude.”

Before vaccinations were widely available, covid-19 tests were considered one of the few tools to help control the spread of the coronavirus.

That’s why then-candidate Joe Biden promised during the 2020 presidential campaign to boost the United States’ testing capacity as one way he would “beat covid-19.”

Specifically, Biden’s campaign website promised that, if elected, he would “double the number of drive-through testing sites” and “invest in next-generation testing, including at-home tests and instant tests, so we can scale up our testing capacity by orders of magnitude.”

KHN has teamed up with our partners at PolitiFact to analyze Biden’s promises during the 2020 presidential campaign. Now that Biden has been president almost five months, we checked how he has done on this one. Experts say testing capacity has improved. At the same time, testing demand has decreased and part of Biden’s promise — doubling the number of drive-thru testing sites — is harder to pin down.

In February, about a month after Biden took office, his administration announced at a news briefing that it would invest more than $1.6 billion in covid testing. These funds would, among other things, expand testing in schools and other congregate settings, increase domestic manufacturing of testing supplies, and help track covid variants via genetic sequencing.

Then, Biden’s American Rescue Plan, which successfully passed through both chambers of Congress in March, also allocated funds specifically to expand testing.

On March 17, the Department of Health and Human Services announced that $10 billion from that legislation would be devoted to screening and testing so schools could reopen, and $2.25 billion to scaling up testing in underserved populations as well as providing new guidance. An additional $4.8 billion was allotted in May to reimburse health care providers for testing uninsured people for the coronavirus.

Dr. Marcus Plescia, chief medical officer of the Association of State and Territorial Health Officials, the organization representing state public health agencies, said states have begun to receive their American Rescue Plan funds and are starting to plan how testing will be implemented to help schools conduct classes in person in the fall.

But whether Biden was successful in doubling the number of drive-thru testing sites is unclear. KHN and PolitiFact asked various testing experts for their take, and they generally said they weren’t aware of any data that showed the number of sites had doubled. Some hypothesized, though, that this may have been because many public health resources were shifted away from testing sites to staff and to set up vaccination sites once covid vaccines became available to the public.

“I think states did shift their efforts to vaccination, because that was the move in the spring,” said Plescia. But as more people were vaccinated, demand dropped, and “if we had those drive-thru testing sites we ended up closing them,” he added. “It was a promise we ended up not needing to keep.”

Indeed, there have been reports of shuttered testing sites across the U.S. In Florida all 27 state-run testing sites closed at the end of May. Oklahoma also recently closed a mass testing site once demand fell to fewer than 50 tests a day and, in late May, New Jersey closed the state’s first outdoor testing site.

The Johns Hopkins University Testing Tracker shows that testing demand in the U.S. has significantly dropped. In January, about 2 million tests were conducted in a day. In May, that number dropped to about 850,000. This reduction has occurred at the same time the number of Americans getting vaccinated is rising and covid cases and deaths are dropping.

The Centers for Disease Control and Prevention also recently recommended that vaccinated people who have been exposed to someone with covid no longer need to be tested if asymptomatic, and that vaccinated people can be excluded from workplace testing in most instances.

Still, Plescia thinks that if future outbreaks occur in certain areas and more tests are required, states would be able to scale up to meet the need. Especially because of the increased availability of at-home tests — another Biden focus.

So far, the administration has contracted with several private companies to ensure the production and distribution of both rapid and at-home covid tests.

Ellume, an Australian diagnostics company, was the first to receive an emergency use authorization from the Food and Drug Administration for an at-home test. In February, the Department of Defense announced it had awarded Ellume almost $232 million to build a U.S. factory and increase home-test production. The contract also includes the allocation of 8.5 million home tests to the federal government, which must be provided by the end of 2021.

Abbott, another diagnostics company, received significant funds from the federal government for tests during both the Biden and Trump administrations. In March, HHS announced that Abbott had received a contract to deliver 50 million of its rapid point-of-care tests to long-term care facilities.

Currently, five over-the-counter at-home tests have been authorized for emergency use by the FDA. In addition to the Ellume and Abbott tests, which provide results at home in 15 minutes, a Labcorp test is also available over the counter, but its results take one or two days to return.

The increase in supply and decrease in demand could mean some testing efforts originally envisioned by the Biden administration might not be rolled out and the U.S. might never get to “orders-of-magnitude” increases in testing, Josh Michaud, associate director of global health policy at KFF, wrote in an email.

Overall, though, despite the number of drive-thru or mass-testing sites closed down, there is now a greater availability of covid tests. The Biden administration has also provided significant funding toward testing, even if some of it has been redirected.

“In general, I think testing is much better,” Jeffrey Schlegelmilch, director of the Columbia University National Center for Disaster Preparedness, wrote in an email. “There are easier-to-access options, and the wait times seem to be much faster for results. … There are also more resources available to state and local health departments to perform testing. So I would qualify this as a promise kept.”

So would we. We rate this a Promise Kept.

Source List

The Associated Press, “OU Health Closing Public Coronavirus Testing as Demand Drops,” May 27, 2021

Bradenton Herald, “State-Run COVID Testing Sites Closing by May 28. Manatee, Sarasota Sites to Close Saturday,” May 12, 2021

Centers for Disease Control and Prevention, “Interim Public Health Recommendations for Fully Vaccinated People,” May 28, 2021

CNBC, “Biden Administration to Invest Over $1.6 Billion to Expand Covid Testing, Sequencing,” Feb. 17, 2021

CVS Health, “Over-the-Counter COVID-19 Testing Now Available at CVS Pharmacy,” April 19, 2021

Department of Defense, “DOD Awards $231.8 Million Contract to Ellume USA LLC to Increase Domestic Production Capacity and Deliver COVID-19 Home Tests,” Feb. 1, 2021

Department of Health and Human Services, “Biden Administration Announces Actions to Expand COVID-19 Testing,” Feb. 17, 2021

Department of Health and Human Services, “Biden Administration to Invest More Than $12 Billion to Expand COVID-19 Testing,” March 17, 2021

Department of Health and Human Services, “HHS to Dedicate $4.8 Billion From American Rescue Plan to COVID-19 Testing for the Uninsured,” May 25, 2021

Email exchange with Aly Morici, director of public affairs at Abbott, June 7, 2021

Email interview with Jeffrey Schlegelmilch, director of the Columbia University National Center for Disaster Preparedness, June 7, 2021

Email interview with Josh Michaud, associate director for global health policy at KFF, June 4, 2021

FierceBiotech.com, “CVS, Walgreens Begin Rolling Out Over-the-Counter COVID Tests From Abbott, Ellume and More,” April 19, 2021

Food and Drug Administration, Coronavirus (COVID-19) Update: June 8, 2021, June 8, 2021

Healthline, “COVID-19 Rapid Tests Now Available at Pharmacies: What to Know,” April 22, 2021

Johns Hopkins University Coronavirus Tracker, Daily State-by-State Testing Trends, accessed June 8, 2021

KHN, “Backed by Millions in Public and Private Cash, Rapid Covid Tests Are Coming to Stores Near You,” April 1, 2021

Patch.com, “COVID-19 Testing Site Closes in Hoboken, After 60,000th Test,” May 21, 2021

Phone interview with Gigi Gronvall, a senior scholar at the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, June 8, 2021

Phone interview with Dr. Marcus Plescia, chief medical officer of the Association for State and Territorial Health Officials, June 8, 2021

Phone interview with Dr. Leana Wen, visiting professor of health policy and management at the George Washington University, June 8, 2021

Politico, “Biden Admin Reroutes Billions in Emergency Stockpile, Covid Funds to Border Crunch,” April 15, 2021

The Wayback Machine, JoeBiden.com/covid19/, accessed June 9, 2021

The White House, Press Briefing by White House COVID-19 Response Team and Public Health Officials, Feb. 17, 2021

Subscribe to KHN's free Morning Briefing.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.